James Eric Schmitt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
James Eric Schmitt has a total of 386 co-authors. Here are the top co-authors by number of shared publications:
Michael C. Neale
Departments of Psychiatry and Genetics Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University Richmond Virginia USA
20 shared publicationsStephan Eliez
10 shared publications- Gregory L. Wallace
The George Washington University
8 shared publications Jay N. Giedd
Child Psychiatry Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA
6 shared publications- Jay Norman Giedd
Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD, USA
6 shared publications Kenneth S. Kendler
Departments of Psychiatry, State University of New York Upstate Medical University, Syracuse, New York
6 shared publications
Latest Publications
- Open Access
- 6 August 2025
- Published by Wiley in Human Brain Mapping
- Vol. 46 (11) , e70300
The Genetics of Cerebellar Structure and Associations With Cognitive Performance: A Twin Magnetic Resonance Imaging Study
The cerebellum, traditionally associated with motor control, is increasingly recognized for its involvement in higher‐order cognitive functions. However, the role of cerebellar subregions in cognition remains underexplored, as are the roles of genetic factors on cerebellar structure and brain‐behavioral associations. The primary goal of this study was to investigate the relationship between cerebellar subregion volumes and cognitive performance. A secondary aim was to quantify the genetic contributions to cerebellar structure and determine the degree to which any brain‐behavior associations were genetically mediated. 3T anatomic MRI data from N = 932 typically developing individuals from the Human Connectome Project were used for this study. Twenty‐seven cerebellar regions of interest (ROIs) were automatically parcellated using CerebNet. Three additional lobar‐level ROIs were derived from smaller measures. Nine functional domains (six cognitive and three motor) related to known or suspected cerebellar function were selected. Linear regression analyses were conducted to identify correlations between cerebellar volumes and cognitive outcomes, adjusting for age, sex, and overall brain volume. Univariate and bivariate quantitative genetic modeling was then performed in OpenMx. There were numerous statistically significant phenotypic associations between cognitive measures and cerebellar lobar and lobular volumes, particularly in the IPL, AL, bilateral cortices, left lobule V, right lobule VI, vermis, and vermis lobule VIII, each meeting the threshold of p < 0.02 across at least four out of nine cognitive domains. The vermis and vermis lobule VIII were of particular note, showing even stronger associations (p < 0.0009 across three domains). Cognitive measures were modestly heritable, and cerebellar ROIs were highly heritable. Quantitative genetic models suggested that brain–behavior associations are largely driven by shared environmental factors. Our findings identify novel associations between specific cerebellar subregions and cognitive performance, highlighting the vermis as a critical structure. We also provide a detailed map of the quantitative genetics of human cerebellar structure. Future studies are warranted.
- 6 August 2025
- Published by Wiley in Human Brain Mapping
- Vol. 46 (11) , e70300
Open AccessThe Genetics of Cerebellar Structure and Associations With Cognitive Performance: A Twin Magnetic Resonance Imaging Study
The cerebellum, traditionally associated with motor control, is increasingly recognized for its involvement in higher‐order cognitive functions. However, the role of cerebellar subregions in cognition remains underexplored, as are the roles of genetic factors on cerebellar structure and brain‐behavioral associations. The primary goal of this study was to investigate the relationship between cerebellar subregion volumes and cognitive performance. A secondary aim was to quantify the genetic contributions to cerebellar structure and determine the degree to which any brain‐behavior associations were genetically mediated. 3T anatomic MRI data from N = 932 typically developing individuals from the Human Connectome Project were used for this study. Twenty‐seven cerebellar regions of interest (ROIs) were automatically parcellated using CerebNet. Three additional lobar‐level ROIs were derived from smaller measures. Nine functional domains (six cognitive and three motor) related to known or suspected cerebellar function were selected. Linear regression analyses were conducted to identify correlations between cerebellar volumes and cognitive outcomes, adjusting for age, sex, and overall brain volume. Univariate and bivariate quantitative genetic modeling was then performed in OpenMx. There were numerous statistically significant phenotypic associations between cognitive measures and cerebellar lobar and lobular volumes, particularly in the IPL, AL, bilateral cortices, left lobule V, right lobule VI, vermis, and vermis lobule VIII, each meeting the threshold of p < 0.02 across at least four out of nine cognitive domains. The vermis and vermis lobule VIII were of particular note, showing even stronger associations (p < 0.0009 across three domains). Cognitive measures were modestly heritable, and cerebellar ROIs were highly heritable. Quantitative genetic models suggested that brain–behavior associations are largely driven by shared environmental factors. Our findings identify novel associations between specific cerebellar subregions and cognitive performance, highlighting the vermis as a critical structure. We also provide a detailed map of the quantitative genetics of human cerebellar structure. Future studies are warranted.
- Open Access
- 1 January 2025
- Published by AOSIS in South African Journal of Radiology
- Vol. 29 (1) , 8
Frequency of imaging phenotypes of pulmonary interstitial fibrosis
Background: Evaluation of diffuse interstitial lung disease (ILD) in thoracic imaging is complicated. Radiologists often use a pattern approach to interpretation; however, they are rarely aware of the statistical frequency of disease presentation. Objectives: To evaluate the relative frequency of causes of fibrotic ILD as a function of imaging patterns. Method: A CT database of 396 cases of fibrotic ILD was amassed from an institutional diffuse lung disease registry and retrospective search of medical records. Three radiologists and one pulmonologist independently and blindly reviewed the CT scans for the distribution of fibrosis, predominant feature and non-pulmonary findings. Results: Peripheral fibrosis was most common (291/396, 73.5%), usually caused by idiopathic pulmonary fibrosis (IPF) and connective tissue diseases-related interstitial lung disease (CTD-ILD) but occasionally by hypersensitivity pneumonitis (HP), idiopathic nonspecific interstitial pneumonia (iNSIP) and asbestosis. Peripheral fibrosis with honeycombing was usually IPF and without honeycombing, was usually CTD-ILD. Peripheral fibrosis with pleural plaques was always asbestosis. Peripheral fibrosis with oesophageal dilatation was usually connective tissue diseases. Consolidative-like peripheral fibrosis was CTD-ILD. Axial fibrosis (61/396, 15.4%) was usually sarcoidosis, HP, CTD-ILD or silicosis. Axial fibrosis with predominantly consolidative-like fibrosis, honeycombing, or reticulation was usually sarcoidosis. Axial fibrosis predominated by ground glass opacity was usually HP or CTD-ILD. Lymph node calcification or short axis > 17 mm increased the probability that axial fibrosis was due to sarcoidosis. The non-specific fibrosis phenotype was uncommon (44/396, 11.1%), usually CTD-ILD (25/44, 57%) but also HP, IPF, iNSIP or asbestosis. Conclusion: Patterns of lung fibrosis provide guidelines to identify the cause. Contribution: A flow diagram that predicts the relative frequency of the causes of 10 patterns of ILD.
- 1 January 2025
- Published by AOSIS in South African Journal of Radiology
- Vol. 29 (1) , 8
Open AccessFrequency of imaging phenotypes of pulmonary interstitial fibrosis
Background: Evaluation of diffuse interstitial lung disease (ILD) in thoracic imaging is complicated. Radiologists often use a pattern approach to interpretation; however, they are rarely aware of the statistical frequency of disease presentation. Objectives: To evaluate the relative frequency of causes of fibrotic ILD as a function of imaging patterns. Method: A CT database of 396 cases of fibrotic ILD was amassed from an institutional diffuse lung disease registry and retrospective search of medical records. Three radiologists and one pulmonologist independently and blindly reviewed the CT scans for the distribution of fibrosis, predominant feature and non-pulmonary findings. Results: Peripheral fibrosis was most common (291/396, 73.5%), usually caused by idiopathic pulmonary fibrosis (IPF) and connective tissue diseases-related interstitial lung disease (CTD-ILD) but occasionally by hypersensitivity pneumonitis (HP), idiopathic nonspecific interstitial pneumonia (iNSIP) and asbestosis. Peripheral fibrosis with honeycombing was usually IPF and without honeycombing, was usually CTD-ILD. Peripheral fibrosis with pleural plaques was always asbestosis. Peripheral fibrosis with oesophageal dilatation was usually connective tissue diseases. Consolidative-like peripheral fibrosis was CTD-ILD. Axial fibrosis (61/396, 15.4%) was usually sarcoidosis, HP, CTD-ILD or silicosis. Axial fibrosis with predominantly consolidative-like fibrosis, honeycombing, or reticulation was usually sarcoidosis. Axial fibrosis predominated by ground glass opacity was usually HP or CTD-ILD. Lymph node calcification or short axis > 17 mm increased the probability that axial fibrosis was due to sarcoidosis. The non-specific fibrosis phenotype was uncommon (44/396, 11.1%), usually CTD-ILD (25/44, 57%) but also HP, IPF, iNSIP or asbestosis. Conclusion: Patterns of lung fibrosis provide guidelines to identify the cause. Contribution: A flow diagram that predicts the relative frequency of the causes of 10 patterns of ILD.
- Open Access
- 5 December 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-21
Tbx1 haploinsufficiency leads to local skull deformity, paraflocculus and flocculus dysplasia, and motor-learning deficit in 22q11.2 deletion syndrome
Neurodevelopmental disorders are thought to arise from intrinsic brain abnormalities. Alternatively, they may arise from disrupted crosstalk among tissues. Here we show the local reduction of two vestibulo-cerebellar lobules, the paraflocculus and flocculus, in mouse models and humans with 22q11.2 deletion syndrome (22q11DS). In mice, this paraflocculus/flocculus dysplasia is associated with haploinsufficiency of the Tbx1 gene. Tbx1 haploinsufficiency also leads to impaired cerebellar synaptic plasticity and motor learning. However, neural cell compositions and neurogenesis are not altered in the dysplastic paraflocculus/flocculus. Interestingly, 22q11DS and Tbx1+/– mice have malformations of the subarcuate fossa, a part of the petrous temporal bone, which encapsulates the paraflocculus/flocculus. Single-nuclei RNA sequencing reveals that Tbx1 haploinsufficiency leads to precocious differentiation of chondrocytes to osteoblasts in the petrous temporal bone autonomous to paraflocculus/flocculus cell populations. These findings suggest a previously unrecognized pathogenic structure/function relation in 22q11DS in which local skeletal deformity and cerebellar dysplasia result in behavioral deficiencies.
- 5 December 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-21
Open AccessTbx1 haploinsufficiency leads to local skull deformity, paraflocculus and flocculus dysplasia, and motor-learning deficit in 22q11.2 deletion syndrome
Neurodevelopmental disorders are thought to arise from intrinsic brain abnormalities. Alternatively, they may arise from disrupted crosstalk among tissues. Here we show the local reduction of two vestibulo-cerebellar lobules, the paraflocculus and flocculus, in mouse models and humans with 22q11.2 deletion syndrome (22q11DS). In mice, this paraflocculus/flocculus dysplasia is associated with haploinsufficiency of the Tbx1 gene. Tbx1 haploinsufficiency also leads to impaired cerebellar synaptic plasticity and motor learning. However, neural cell compositions and neurogenesis are not altered in the dysplastic paraflocculus/flocculus. Interestingly, 22q11DS and Tbx1+/– mice have malformations of the subarcuate fossa, a part of the petrous temporal bone, which encapsulates the paraflocculus/flocculus. Single-nuclei RNA sequencing reveals that Tbx1 haploinsufficiency leads to precocious differentiation of chondrocytes to osteoblasts in the petrous temporal bone autonomous to paraflocculus/flocculus cell populations. These findings suggest a previously unrecognized pathogenic structure/function relation in 22q11DS in which local skeletal deformity and cerebellar dysplasia result in behavioral deficiencies.
- Open Access
- 10 October 2024
- Published by Springer Nature in Communications Biology
- Vol. 7 (1) , 1-12
The genetics of spatiotemporal variation in cortical thickness in youth
Prior studies have shown strong genetic effects on cortical thickness (CT), structural covariance, and neurodevelopmental trajectories in childhood and adolescence. However, the importance of genetic factors on the induction of spatiotemporal variation during neurodevelopment remains poorly understood. Here, we explore the genetics of maturational coupling by examining 308 MRI-derived regional CT measures in a longitudinal sample of 677 twins and family members. We find dynamic inter-regional genetic covariation in youth, with the emergence of regional subnetworks in late childhood and early adolescence. Three critical neurodevelopmental epochs in genetically-mediated maturational coupling were identified, with dramatic network strengthening near eleven years of age. These changes are associated with statistically-significant (empirical p-value <0.0001) increases in network strength as measured by average clustering coefficient and assortativity. We then identify genes from the Allen Human Brain Atlas with similar co-expression patterns to genetically-mediated structural covariation in children. This set was enriched for genes involved in potassium transport and dendrite formation. Genetically-mediated CT-CT covariance was also strongly correlated with expression patterns for genes located in cells of neuronal origin.
- 10 October 2024
- Published by Springer Nature in Communications Biology
- Vol. 7 (1) , 1-12
Open AccessThe genetics of spatiotemporal variation in cortical thickness in youth
Prior studies have shown strong genetic effects on cortical thickness (CT), structural covariance, and neurodevelopmental trajectories in childhood and adolescence. However, the importance of genetic factors on the induction of spatiotemporal variation during neurodevelopment remains poorly understood. Here, we explore the genetics of maturational coupling by examining 308 MRI-derived regional CT measures in a longitudinal sample of 677 twins and family members. We find dynamic inter-regional genetic covariation in youth, with the emergence of regional subnetworks in late childhood and early adolescence. Three critical neurodevelopmental epochs in genetically-mediated maturational coupling were identified, with dramatic network strengthening near eleven years of age. These changes are associated with statistically-significant (empirical p-value <0.0001) increases in network strength as measured by average clustering coefficient and assortativity. We then identify genes from the Allen Human Brain Atlas with similar co-expression patterns to genetically-mediated structural covariation in children. This set was enriched for genes involved in potassium transport and dendrite formation. Genetically-mediated CT-CT covariance was also strongly correlated with expression patterns for genes located in cells of neuronal origin.
- Open Access
Neuroanatomical Correlates of Cognitive Dysfunction in 22q11.2 Deletion Syndrome
22q11.2 Deletion Syndrome (22q11.2DS), the most common chromosomal microdeletion, presents as a heterogeneous phenotype characterized by an array of anatomical, behavioral, and cognitive abnormalities. Individuals with 22q11.2DS exhibit extensive cognitive deficits, both in overall intellectual capacity and focal challenges in executive functioning, attentional control, perceptual abilities, motor skills, verbal processing, as well as socioemotional operations. Heterogeneity is an intrinsic factor of the deletion’s clinical manifestation in these cognitive domains. Structural imaging has identified significant changes in volume, thickness, and surface area. These alterations are closely linked and display region-specific variations with an overall increase in abnormalities following a rostral-caudal gradient. Despite the extensive literature developing around the neurocognitive and neuroanatomical profiles associated with 22q11.2DS, comparatively little research has addressed specific structure–function relationships between aberrant morphological features and deficient cognitive processes. The current review attempts to categorize these limited findings alongside comparisons to populations with phenotypic and structural similarities in order to answer to what degree structural findings can explain the characteristic neurocognitive deficits seen in individuals with 22q11.2DS. In integrating findings from structural neuroimaging and cognitive assessments, this review seeks to characterize structural changes associated with the broad neurocognitive challenges faced by individuals with 22q11.2DS.
Open AccessNeuroanatomical Correlates of Cognitive Dysfunction in 22q11.2 Deletion Syndrome
22q11.2 Deletion Syndrome (22q11.2DS), the most common chromosomal microdeletion, presents as a heterogeneous phenotype characterized by an array of anatomical, behavioral, and cognitive abnormalities. Individuals with 22q11.2DS exhibit extensive cognitive deficits, both in overall intellectual capacity and focal challenges in executive functioning, attentional control, perceptual abilities, motor skills, verbal processing, as well as socioemotional operations. Heterogeneity is an intrinsic factor of the deletion’s clinical manifestation in these cognitive domains. Structural imaging has identified significant changes in volume, thickness, and surface area. These alterations are closely linked and display region-specific variations with an overall increase in abnormalities following a rostral-caudal gradient. Despite the extensive literature developing around the neurocognitive and neuroanatomical profiles associated with 22q11.2DS, comparatively little research has addressed specific structure–function relationships between aberrant morphological features and deficient cognitive processes. The current review attempts to categorize these limited findings alongside comparisons to populations with phenotypic and structural similarities in order to answer to what degree structural findings can explain the characteristic neurocognitive deficits seen in individuals with 22q11.2DS. In integrating findings from structural neuroimaging and cognitive assessments, this review seeks to characterize structural changes associated with the broad neurocognitive challenges faced by individuals with 22q11.2DS.
- Open Access
Brain growth charts of “clinical controls” for quantitative analysis of clinically acquired brain MRI
Background: Brain MRIs acquired in clinical settings represent a valuable and underutilized scientific resource for investigating neurodevelopment. Utilization of these clinical scans has been limited because of their clinical acquisition and technical heterogeneity. These barriers have curtailed the interpretability and scientific value of retrospective studies of clinically acquired brain MRIs, compared to studies of prospectively acquired research quality brain MRIs. Purpose: To develop a scalable and rigorous approach to generate clinical brain growth chart models, to benchmark neuroanatomical differences in clinical MRIs, and to validate clinically-derived brain growth charts against those derived from large-scale research studies. Materials and Methods: We curated a set of clinical MRI S cans with L imited I maging P athology (SLIP) – so-called “clinical controls” – from an urban pediatric healthcare system acquired between 2005 and 2020. The curation process included manual review of signed radiology reports, as well as automated and manual quality review of images without gross pathology. We measured global and regional volumetric imaging phenotypes in the SLIP sample using two alternative, advanced image processing pipelines, and quantitatively compared clinical brain growth charts to research brain growth charts derived from >123,000 MRIs. Results: The curated SLIP dataset included 372 patients scanned between the ages of 28 days post-birth and 22.2 years across nine 3T MRI scanners. Clinical brain growth charts were highly similar to growth charts derived from large-scale research datasets, in terms of the normative developmental trajectories predicted by the models. The clinical indication of the scans did not significantly bias the output of clinical brain charts. Tens of thousands of additional healthcare system scans meet inclusion criteria to be included in future brain growth charts. Conclusion: Brain charts derived from clinical-controls are highly similar to brain charts from research-controls, suggesting that curated clinical scans could be used to supplement research datasets. Summary Statement: Brain growth charts of pediatric clinical MRIs with limited imaging pathology (N=372) are highly correlated with charts from a large aggregated set of research controls (N>120,000). Key Results: A cohort of brain MRI scans with limited reported imaging pathology (N=372, 186 female; ages 0.07 - 22.2 years, median = 10.2) were identified using signed radiology reports and processed using two segmentation pipelines. Growth charts generated from these scans are highly correlated with growth charts from a large aggregated set of research controls (r range 0.990 - 0.999). There was no evidence of bias due to the reason for each scan.
Open AccessBrain growth charts of “clinical controls” for quantitative analysis of clinically acquired brain MRI
Background: Brain MRIs acquired in clinical settings represent a valuable and underutilized scientific resource for investigating neurodevelopment. Utilization of these clinical scans has been limited because of their clinical acquisition and technical heterogeneity. These barriers have curtailed the interpretability and scientific value of retrospective studies of clinically acquired brain MRIs, compared to studies of prospectively acquired research quality brain MRIs. Purpose: To develop a scalable and rigorous approach to generate clinical brain growth chart models, to benchmark neuroanatomical differences in clinical MRIs, and to validate clinically-derived brain growth charts against those derived from large-scale research studies. Materials and Methods: We curated a set of clinical MRI S cans with L imited I maging P athology (SLIP) – so-called “clinical controls” – from an urban pediatric healthcare system acquired between 2005 and 2020. The curation process included manual review of signed radiology reports, as well as automated and manual quality review of images without gross pathology. We measured global and regional volumetric imaging phenotypes in the SLIP sample using two alternative, advanced image processing pipelines, and quantitatively compared clinical brain growth charts to research brain growth charts derived from >123,000 MRIs. Results: The curated SLIP dataset included 372 patients scanned between the ages of 28 days post-birth and 22.2 years across nine 3T MRI scanners. Clinical brain growth charts were highly similar to growth charts derived from large-scale research datasets, in terms of the normative developmental trajectories predicted by the models. The clinical indication of the scans did not significantly bias the output of clinical brain charts. Tens of thousands of additional healthcare system scans meet inclusion criteria to be included in future brain growth charts. Conclusion: Brain charts derived from clinical-controls are highly similar to brain charts from research-controls, suggesting that curated clinical scans could be used to supplement research datasets. Summary Statement: Brain growth charts of pediatric clinical MRIs with limited imaging pathology (N=372) are highly correlated with charts from a large aggregated set of research controls (N>120,000). Key Results: A cohort of brain MRI scans with limited reported imaging pathology (N=372, 186 female; ages 0.07 - 22.2 years, median = 10.2) were identified using signed radiology reports and processed using two segmentation pipelines. Growth charts generated from these scans are highly correlated with growth charts from a large aggregated set of research controls (r range 0.990 - 0.999). There was no evidence of bias due to the reason for each scan.
- 1 January 2023
- Published by Springer Nature
- p. 175-199
A Practical Guide to Imaging Spinal Trauma
- 1 January 2023
- Published by Elsevier in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
- Vol. 8 (1) , 79-90
A Comprehensive Analysis of Cerebellar Volumes in the 22q11.2 Deletion Syndrome
- 1 January 2023
- Published by Elsevier in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
- Vol. 8 (1) , 79-90
A Comprehensive Analysis of Cerebellar Volumes in the 22q11.2 Deletion Syndrome
- Open Access
- 15 December 2022
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 44 (1) , 105-110
Spinal Cord Sarcoidosis Occurring at Sites of Spondylotic Stenosis, Mimicking Spondylotic Myelopathy: A Case Series and Review of the Literature
Sarcoidosis is a multisystem granulomatous disease, with intramedullary spinal cord involvement seen in <1% of cases. This case series illustrates the clinical presentations and imaging findings of 5 patients with intramedullary spinal neurosarcoidosis occurring at sites of spondylotic spinal canal stenosis, which can be indistinguishable from spondylotic myelopathy with cord enhancement. Both entities are most common in middle-aged men and present with weeks to months of motor and sensory symptoms. On imaging, both can have focal spinal cord enhancement and longitudinally extensive signal abnormality centered at or just below the level of spinal canal stenosis. On the basis of our experience, we suggest that in patients with cord enhancement centered at or just below a site of spinal canal stenosis, consideration should be given to chest imaging and lymph node biopsy when applicable, to assess for the possibility of underlying sarcoidosis before surgical decompression.
- 15 December 2022
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 44 (1) , 105-110
Open AccessSpinal Cord Sarcoidosis Occurring at Sites of Spondylotic Stenosis, Mimicking Spondylotic Myelopathy: A Case Series and Review of the Literature
Sarcoidosis is a multisystem granulomatous disease, with intramedullary spinal cord involvement seen in <1% of cases. This case series illustrates the clinical presentations and imaging findings of 5 patients with intramedullary spinal neurosarcoidosis occurring at sites of spondylotic spinal canal stenosis, which can be indistinguishable from spondylotic myelopathy with cord enhancement. Both entities are most common in middle-aged men and present with weeks to months of motor and sensory symptoms. On imaging, both can have focal spinal cord enhancement and longitudinally extensive signal abnormality centered at or just below the level of spinal canal stenosis. On the basis of our experience, we suggest that in patients with cord enhancement centered at or just below a site of spinal canal stenosis, consideration should be given to chest imaging and lymph node biopsy when applicable, to assess for the possibility of underlying sarcoidosis before surgical decompression.